Metabolic Effects of Treatment in Patients With Recently Diagnosed Type 2 Diabetes

Aristotle University Of Thessaloniki

Status and phase: Completed; Phase 4

Conditions: Type 2 Diabetes Mellitus

Treatments: Drug: metformin; Drug: Anti-diabetic medications; Drug: rosiglitazone

Study type: Interventional

Funder types: Other

Identifiers

NCT00373178

020401975

Details and patient eligibility

About

The aim of the present study is to investigate the influence of several anti-diabetic regimens (metformin,glitazone,sulfonylurea,glinidine) and diet on metabolic parameters in patients with recently diagnosed type 2 diabetes.

Enrollment: 100 patients

Sex: All

Ages: 40 to 70 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Recently diagnosed type 2 diabetes
• No previous anti-diabetic medications

Exclusion criteria

• Heart failure
• Renal disease
• Liver disease
• Life-threatening diseases

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

100 participants in 1 patient group

Metformin,lifestyle counselling

Active Comparator group

Treatment:

Drug: rosiglitazone

Drug: Anti-diabetic medications

Drug: metformin